More details on Medtronic-Covidien shareholder vote; Wearable fitness trackers lack accuracy;

@FierceMedDev: ICYMI: Qiagen exceeds 2014 placement goals for molecular Dx, hedges its bets on continued success. FierceDiagnostics story | Follow @FierceMedDev

@StacyALawrence: ICYMI: PureTech bumps its early life science funds up to $107M. Article | Follow @StacyALawrence

@EmilyWFierce: Roche shells out $1B plus milestones for a majority share in Foundation Medicine. Release | Follow @EmilyWFierce

> Medtronic's ($MDT) shareholder vote on its looming merger with Covidien ($COV) passed by an overwhelming vote of 75% yes, to 25% no. In addition, an SEC filing reveals that the plan to cover $63 million in taxes owed by top executives and directors also passed overwhelmingly, with 72.5% of shareholders in favor. Story

> Fitness trackers are off the mark by 10% to 15% compared to laboratory measurement of activity, according to an Iowa State University study. Story

> A study found that wearing compression stockings at night can improve sleep apnea. Story

Biotech News

@FierceBiotech: $SHPG nabs NPS's rare disease drug portfolio in $5.2B buyout. News | Follow @FierceBiotech

@JohnCFierce: $JNJ steps in with a $509M-plus deal to partner on a tau vaccine for Alzheimer's. Report | Follow @JohnCFierce

@DamianFierce: And so now Roche owns 56% of Foundation Medicine. Story | Follow @DamianFierce

> Mersana lines up for $300M in an R&D deal with Takeda. More

> Bristol-Myers aces a lung cancer trial with its blockbuster in waiting. Story

> Biogen Idec grabs Convergence, neuropathic pain portfolio in $675M buyout. Report

Pharma News

@FiercePharma: AmerisourceBergen storms into animal health with $2.5B purchase of MWI. FierceAnimalHealth story | Follow @FiercePharma

@CarlyHFierce: Off to #JPM15! Picture | Follow @CarlyHFierce

> Pharma calls for NICE overhaul as special cancer drugs fund nixes meds. Report

> Ambitious Actavis joins JPMorgan news fray with Street-beating EPS. Story

> Bristol-Myers scores lung cancer survival data on Opdivo as Merck preps for Keytruda filing. Article

Biotech IT News

> Adaptive buys Sequenta to pool immune sequencing capabilities. Story

> FDA to publish guidance on social media and clinical trial e-consent in 2015. More

> Novartis picks Qualcomm tech to enable remote collection of trial data. Article

> 23andMe strikes $60M Genentech deal to continue pivot to database-driven R&D. Report

> Biogen Idec inks $30M genetic R&D alliance with Columbia University. Item

CRO News

> Evotec extends a biotech deal with $13M on the line. Report

> Quintiles' Novella partners up for cardio device R&D. Story

> PPD's in-house biotech pairs up with J&J. Article

> AMRI spends $60M to beef up its manufacturing heft. More

> WuXi buys big into genomics with NextCODE deal. News

Animal Health News

> New strain of virulent PEDv found on Minnesota hog farm. Article

> Catterton offloads PetVet hospital network to Canadian pension plan for $440M. More

> Petco banishes China-made treats from shelves. Item

> Nexvet plans $60M IPO to advance pipeline of pet therapeutics. Story

> Aratana scores a 'first' with USDA approval for canine lymphoma drug. Report

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.